EGFR modulates cancer cell growth and proliferation by modifying activities of protein tyrosine kinases, cell surface signal transduction, etc., which could inhibit early events in cancer progression while histone deacetylase inhibition results in chromatid realignment and silencing via DNA methylation, and is considered as an epigenetic mechanism for cancer interception.
..the multifunctional small CUDC-101 molecule inhibits histone deacetylase,EGFR and HER2.CUDC - 101 has multifunctional activity and also offering the potential advantages over a single targetted molecules and also it reduces the level of total phosphorylated MET through HDAC inhibitory in NSCLC.and some of study published through american association for cancer research ,provided the supportive evidences for AXL overexpressions and a loss of E-Cadherin expression and the drug resistance and the metastatic properties and processes also.and the EGFR -receptor tyrosine kinase promotes the cell proliferation and survival is abnormally overexpressed in numerous tumors of epithelial origin.